Drugs / HEC83518
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04667429 | Jan → Jul 2021 | insomnia | Sunshine Lake Pharma Co., Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT04596007 | Apr → Sep 2020 | insomnia | Sunshine Lake Pharma Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HEC83518 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04596007 ↗ |
| Route | Oral | “HEC83518 will be taken orally before sleep for 15 days” NCT04667429 ↗ |